On-Demand Webinar: Strategies for Simplifying Viral Vaccine and Biotherapeutic Discovery

The global COVID-19 pandemic has been a great test of our infrastructure for rapid development of vaccines and biotherapeutics. Indeed, science delivered, and life-saving vaccines were approved for clinical use within a year. Since then, a range of treatments, including antibody-based drugs, have helped reduce the burden of COVID-19 disease.

However, new variants of SARS-CoV-1 and the surprising emergence of Monkeypox infections worldwide are a reminder that we need to keep developing new, more efficient ways to study and combat infectious diseases. In our new on-demand webinar “Strategies for Simplifying Viral Vaccine and Biotherapeutic Discovery”, subject matter experts Dr. David Apiyo and Allan Schell explain how information-rich, high-throughput Sartorius technologies are helping pharmaceutical companies respond to current and emerging pathogens.

This webinar was part of the Microbiology & Infectious Disease Summit 2022 with SelectScience in May 2022.

Complete the Form to Watch Now

About the speakers

David Apiyo
Ph.D., Senior Manager
Octet Applications, Sartorius

David is a Senior Manager, Applications at Sartorius, where he leads a team of Applications Managers focused on the Octet platforms and applications.

David began as a Field Applications Scientist in 2011 and transitioned to the marketing applications team in 2015. Prior to this, David worked as a Senior Development Scientist at Beckman Coulter. David obtained his Ph.D. in Protein Chemistry from Tulane University, New Orleans.

Allan Schell
Field Application Scientist Manager
Sartorius
 

Allan Schell earned a MS in Toxicology from Colorado State University in 2010 and joined Sartorius in 2016 as a FAS supporting the iQue product line. He has over 10 years of experience as an FAS supporting flow cytometry applications and has been a manager of the applications team for Sartorius FAS for over 3 years.